1 |
Bidani AK, Griffin KA. Pathophysiology of hypertensive renal damage: implications for therapy [J]. Hypertension, 2004, 44(5):595-601.
|
2 |
Freedman BI, Iskandar SS, Appel RG. The link between hypertension and nephrosclerosis [J]. Am J Kidney Dis, 1995,25(2): 207-221.
|
3 |
Johnson RJ, Rodríguez-Iturbe B, Schreiner GF, et al.Hypertension: a microvascular and tubulointerstitial disease [J]. J Hypertens Suppl, 2002, 20(3): S1-S7.
|
4 |
Tracy RE. Renal vasculature in essential hypertension: a review of some contrarian evidence [J]. Contrib Nephrol, 2011, 169: 327-336.
|
5 |
刘力生. 中国高血压防治指南2010 [J]. 中华高血压杂志, 2011,19(8): 701-708.
|
6 |
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009,150(9): 604-612.
|
7 |
Hill GS, Heudes D, Jacquot C, et al. Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension [J]. Kidney Int, 2006, 69(5): 823-831.
|
8 |
Hill GS, Heudes D, Bariéty J. Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation [J]. Kidney Int, 2003, 63(3): 1027-1036.
|
9 |
邹万忠. 肾活检病理学[M]. 北京:北京大学医学出版社,2006.
|
10 |
Collins AJ, Foley RN, Chavers B, et al. United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease& end-stage renal disease in the United States [J]. Am J Kidney Dis, 2012, 59(1 Suppl 1): A7, e1-e420.
|
11 |
陈洪, 周春华. 2007年北京市新入血液透析患者病因组成分析[J]. 中国血液净化, 2009, 8(10): 567-570.
|
12 |
Kincaid-Smith P. Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled‘hypertensive nephrosclerosis’ [J]. J Hypertens, 2004, 22(6): 1051-1055.
|
13 |
Schlessinger SD, Tankersley MR, Curtis JJ. Clinical documentation of end-stage renal disease due to hypertension [J].Am J Kidney Dis, 1994, 23(5): 655-660.
|
14 |
Salomaa V, Stinson V, Kark JD, et al. Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study.Atherosclerosis Risk in Communities Study [J]. Circulation,1995, 91(2): 284-290.
|
15 |
Johnson RJ, Segal MS, Srinivas T, et al. Essential hypertension,progressive renal disease, and uric acid: a pathogenetic link [J]. J Am Soc Nephrol, 2005, 16(7): 1909-1919.
|
16 |
Schainuck LI, Striker GE, Cutler RE, et al. Structural-functional correlations in renal disease. II. The correlations [J]. Hum Pathol,1970, 1(4): 631-641.
|
17 |
Striker GE, Schainuck LI, Cutler RE, et al. Structural-functional correlations in renal disease. I. A method for assaying and classifying histopathologic changes in renal disease [J]. Hum Pathol, 1970, 1(4): 615630.
|
18 |
Risdon RA, Sloper JC, De Wardener HE. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis [J].Lancet, 1968, 2(7564): 363-366.
|
19 |
Yu F, Wu LH, Tan Y, et al. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system [J]. Kidney Int, 2010, 77(9): 820-829.
|
20 |
D'Amico G. Tubulointerstitium as predictor of progression of glomerular diseases [J]. Nephron, 1999, 83(4): 289-295.
|
21 |
Cai GY, Chen XM. Immunoglobulin A nephropathy in China:progress and challenges [J]. Am J Nephrol, 2009, 30(3): 268-273.
|